Representative dot-plots exemplify the contrast of CD3+CD4+ T cells expressing IFN-gamma in whole blood samples exposed to polyclonal molecules from participants who experienced mild or severe COVID-19 throughout the follow-up (Figure 2D). This evidence concerns the gene CD4 and COVID-19.